In an exciting development, Canadian scientists are ready to test what’s being described as a “unique” type of vaccine that could potentially prevent HIV infection.
More after the jump!
Scientists from the University of Western Ontario, led by Chil-Yong Kang, Ph.D, are ready to test SAV001, a preventative HIV vaccine that is the first to utilize a “killed whole” HIV-1 virus to stimulate the immune system. The virus in the vaccine is genetically altered in order to prevent infection, and is inactivated with chemicals and radiation for further insurance.
This “killed whole” virus vaccination method is similar to vaccines that have successfully combatted polio, flu, rabies, and hepatitis A.
Trials have already begun with 40 people taking the vaccine to ensure that it isn’t toxic. Now 600 HIV-negative persons that are high-risk for HIV infection will be introduced to the study. The final stage will include 6000 volunteers who will be introduced to SAV001 and tested over three years. Half of these 6000 participants will receive a placebo.
SAV001 has received approval by the US Food and Drug Administration, which will allow US volunteers to participate in the trial. The FDA is known for having the most strict evaluation policies and requirements with regards to human trial subjects.
We can also safely assume that if this is successful there will be a moratorium on Canada jokes.